|
LYSMD3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.47299983111316E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.79509978998271E-10 |
| Normal-vs-Stage2 |
1.523670E-03 |
| Normal-vs-Stage3 |
1.384340E-02 |
| Normal-vs-Stage4 |
5.496400E-02 |
| Stage1-vs-Stage2 |
6.417800E-01 |
| Stage1-vs-Stage3 |
1.974560E-01 |
| Stage1-vs-Stage4 |
4.741000E-01 |
| Stage2-vs-Stage3 |
5.858600E-01 |
| Stage2-vs-Stage4 |
7.323400E-01 |
| Stage3-vs-Stage4 |
9.049800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.34060010157111E-10 |
| Normal-vs-AfricanAmerican |
1.27950000039512E-07 |
| Normal-vs-Asian |
7.542400E-01 |
| Caucasian-vs-AfricanAmerican |
8.957000E-01 |
| Caucasian-vs-Asian |
4.423600E-01 |
| AfricanAmerican-vs-Asian |
4.327800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.82900369796835E-11 |
| Normal-vs-Female |
9.033400E-04 |
| Male-vs-Female |
7.120700E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.5467999999983E-05 |
| Normal-vs-Extreme_Weight |
4.0422998281997E-11 |
| Normal-vs-Obese |
4.29079999997306E-06 |
| Normal-vs-Extreme_Obese |
2.38419999999406E-05 |
| Normal_Weight-vs-Extreme_Weight |
4.081000E-01 |
| Normal_Weight-vs-Obese |
5.585800E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.923600E-01 |
| Extreme_Weight-vs-Obese |
8.676200E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.793000E-01 |
| Obese-vs-Extreme_Obese |
4.104800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.86159999998803E-06 |
| Normal-vs-Age(41-60Yrs) |
1.8907000000068E-06 |
| Normal-vs-Age(61-80Yrs) |
5.94050364455256E-11 |
| Normal-vs-Age(81-100Yrs) |
1.43649999995166E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.262200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.077800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.779200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.444000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.146370E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.110000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.45155023953703E-12 |
| Normal-VS-Type2 PRCC |
2.046800E-04 |
| Normal-VS-KIRP CIMP |
4.375000E-04 |
| Normal-VS-Unclassified PRCC |
2.254000E-02 |
| Type1 PRCC-VS-Type2 PRCC |
4.564400E-02 |
| Type1 PRCC-VS-KIRP CIMP |
5.348400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.856000E-02 |
| Type2 PRCC-VS-KIRP CIMP |
7.056800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.214200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.063800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.03330000000845E-06 |
| Normal-vs-N1 |
1.415570E-02 |
| Normal-vs-N2 |
2.461700E-03 |
| N0-vs-N1 |
1.916990E-01 |
| N0-vs-N2 |
8.562400E-01 |
| N1-vs-N2 |
4.124800E-01 |
|
|
